Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

[1]  D. Judge,et al.  Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism , 2011, Science.

[2]  T. Fujita,et al.  Essential Role of Complement Mannose-Binding Lectin-Associated Serine Proteases-1/3 in the Murine Collagen Antibody-Induced Model of Inflammatory Arthritis , 2010, The Journal of Immunology.

[3]  M. Haskins,et al.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression. , 2010, Molecular genetics and metabolism.

[4]  J. Lambris,et al.  Crosstalk pathways between Toll-like receptors and the complement system. , 2010, Trends in immunology.

[5]  A. Schambach,et al.  A Self-inactivating γ-Retroviral Vector Reduces Manifestations of Mucopolysaccharidosis I in Mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  T. Fujita,et al.  Essential role of Mannose-binding lectin-associated serine protease-1 in activation of the complement factor D , 2010, The Journal of experimental medicine.

[7]  K. Jepsen,et al.  Involvement of the Toll-like receptor 4 pathway and use of TNF-α antagonists for treatment of the mucopolysaccharidoses , 2009, Proceedings of the National Academy of Sciences.

[8]  D. Turk,et al.  Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions , 2009 .

[9]  M. Sands,et al.  Metabolic Adaptations to Interrupted Glycosaminoglycan Recycling* , 2009, The Journal of Biological Chemistry.

[10]  John D Lambris,et al.  Complement-Dependent Neutrophil Recruitment Is Critical for the Development of Elastase-Induced Abdominal Aortic Aneurysm , 2009, Circulation.

[11]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling by ITAM-associated receptors , 2009, Nature Immunology.

[12]  John G. Oakeshott,et al.  Bridging the Synaptic Gap: Neuroligins and Neurexin I in Apis mellifera , 2008, PloS one.

[13]  R. Knutsen,et al.  Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice. , 2008, Molecular genetics and metabolism.

[14]  D. Cheillan,et al.  Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice , 2008, PloS one.

[15]  J. Wilson,et al.  The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness , 2008, Heart and Vessels.

[16]  B. Fingleton.  MMPs as therapeutic targets--still a viable option? , 2008, Seminars in cell & developmental biology.

[17]  M. Haskins,et al.  Gene therapy for mucopolysaccharidosis , 2007, Expert opinion on biological therapy.

[18]  C. Vite,et al.  Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  C. Vite,et al.  Bone marrow transplantation for feline mucopolysaccharidosis I. , 2007, Molecular genetics and metabolism.

[20]  R. Hoft,et al.  A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. , 2007, Molecular genetics and metabolism.

[21]  J. Berry,et al.  Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. , 2006, The American journal of cardiology.

[22]  B. Baxter,et al.  MMP-12 has a role in abdominal aortic aneurysms in mice. , 2005, Surgery.

[23]  S. Ryazantsev,et al.  Cardiac manifestations in the mouse model of mucopolysaccharidosis I. , 2005, Molecular genetics and metabolism.

[24]  Dean Y. Li,et al.  Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. , 2005, American journal of physiology. Heart and circulatory physiology.

[25]  O. Vasiljeva,et al.  Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans , 2005, FEBS letters.

[26]  T. O'Malley,et al.  Gene Therapy Ameliorates Cardiovascular Disease in Dogs With Mucopolysaccharidosis VII , 2004, Circulation.

[27]  M. Bogyo,et al.  Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans* , 2004, Journal of Biological Chemistry.

[28]  J. Berry,et al.  Usefulness of bone marrow transplantation in the Hurler syndrome. , 2003, The American journal of cardiology.

[29]  P. Libby,et al.  Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth , 2003, Circulation research.

[30]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[31]  J. Lemontt,et al.  Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy. , 2003, Molecular genetics and metabolism.

[32]  S. Ryazantsev,et al.  Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Haskins,et al.  Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  G. Aguirre,et al.  Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Cuihua Gao,et al.  Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  T. O'Malley,et al.  Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII , 2000, Bone Marrow Transplantation.

[37]  S. Wilson,et al.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. , 2000, The American journal of pathology.

[38]  S. Evans,et al.  Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings. , 1997, Transplantation.

[39]  R. Maciewicz,et al.  Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D , 1996, International journal of cancer.

[40]  T. Ley,et al.  Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  John C. Anderson,et al.  Age-related changes in amounts and concentrations of collagen and elastin in normotensive human thoracic aorta. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[42]  J. Schofield.  Metabolic and molecular basis of inherited disease: paper versus electronic media , 1995 .

[43]  M. Zuker,et al.  The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. , 1994, The Journal of clinical investigation.

[44]  W. Sly,et al.  Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. , 1991, Blood.

[45]  G. Constantopoulos,et al.  Cardiovascular changes after bone marrow transplantation in dogs with mucopolysaccharidosis I. , 1990, American journal of veterinary research.

[46]  A. Barrett,et al.  Elastinolytic activity of human cathepsin L. , 1986, The Biochemical journal.

[47]  W. Roberts,et al.  The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases. , 1976, The American journal of cardiology.

[48]  A. Beaudet,et al.  Variation in the phenotypic expression of β-glucuronidase deficiency , 1975 .

[49]  D. Brömme,et al.  Role of Cysteine Cathepsins in Extracellular Proteolysis , 2011 .

[50]  A. Schambach,et al.  A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  M. Haskins,et al.  Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. , 2008, The American journal of pathology.

[52]  J. Tolar,et al.  Cardiac Functional and Histopathologic Findings in Humans and Mice with Mucopolysaccharidosis Type I: Implications for Assessment of Therapeutic Interventions in Hurler Syndrome , 2006, Pediatric Research.

[53]  S. Cai,et al.  Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  A. Beaudet,et al.  Variation in the phenotypic expression of beta-glucuronidase deficiency. , 1975, The Journal of pediatrics.

[55]  F. Shofer,et al.  Clinical Characterization of Cardiovascular Abnormalities Associated with Feline Mucopolysaccharidosis I and Vi , 2022 .

[56]  O. Soliman,et al.  Cardiac Abnormalities in Adults with the Attenuated Form of Mucopolysaccharidosis Type I , 2022 .